Sedergin 325 mg | 20 effervescent tablets

Sedergine 325 mg is a medication containing acetylsalicylic acid and is indicated for the symptomatic treatment of fever and pain.

Directions for Use

• Treatment should be as short as possible and limited to the symptomatic period.
• An interval of 4 hours must be observed between two doses of 325 or 500 mg.
• In cases of
  moderate renal insufficiency or after a dose of 1 g, at least 6 hours must elapse between two
  consecutive doses.
  Sedergine is intended for oral use only.
• Dissolve the effervescent tablets in a glass of water and then drink.

Dosage

Adults and children weighing more than 40 kg (approximately 12 years of age)

Mild to moderate pain and fever: 2 to 3 tablets every 4 to 6 hours, as needed.
Do not exceed 12 tablets per 24 hours.

Elderly

Mild to moderate pain and fever: the doses recommended for adults may be administered.

Children weighing up to 40 kg (approximately 12 years of age):

Only as directed by a doctor. The usual dose for children is 60 mg/kg/day.

• Children weighing less than 20 kg:
  Do not administer.
• Children weighing 20 to 27 kg: 1 tablet, up to 4 times a day.
• Children weighing 28 to 33 kg: 1 tablet, up to 5 times a day.
• Children weighing 34 to 40 kg: 1 tablet, up to 6 times a day.

Composition

The active ingredient in this medicine is acetylsalicylic acid. Each tablet contains 325 mg of acetylsalicylic acid. The other ingredients in this medicine are: anhydrous citric acid, sodium bicarbonate,
sodium benzoate, polyvidone.

Warnings

Do not use Sedergine:

• If you are allergic to any of the ingredients in this medicine.
• If you have asthma or an allergic reaction caused by a nonsteroidal anti-inflammatory drug.
• If you have stomach or intestinal ulcers and a history of gastrointestinal bleeding related to previous treatment with an anti-inflammatory drug.
• If you have severe kidney or liver disease.
• If you have severe heart failure.
• If you have a tendency to bleed, a condition with a risk of bleeding, or are being treated with
  anticoagulants.
• In cirrhosis (a liver disease).
• In cases of phenylketonuria.
• During the last trimester of pregnancy.
• In combination with methotrexate in doses of 15 mg/week or more.

Possible side effects

Serious side effects include allergic skin and mucous membrane reactions, asthma attacks, and anaphylactic shock. Consult the package insert for a complete list of known side effects and contact your doctor or pharmacist if you experience any side effects.